Montejo Hernández JD, Lopera JM, Rosselli C, Ronderos I, Daza R, Yama-Mosquera E, Flechas López JA, Jacome Guerrero RL, Contreras Villamizar KM, Machacón Miranda E, Henao Velásquez CM, Romero Jaller KC, Figueroa C, Mejía García CH, Hernández Sierra A, González Sánchez DA, de la Espriella V, Dávila M Ángel, Parra P, Guevara García JG, Uribe Betancur JM, Cárdenas-Garzón K, Zuluaga Peña JR, Zuluaga-Peña JP, Rico Fontalvo J. Evidence-based Colombian consensus and expert opinion regarding the use of sodium-glucose cotransporter type 2 (iSGLT-2) inhibitors in the cardiorenal continuum in patients with chronic kidney disease. Rev. Colomb. Nefrol. [Internet]. 2025 May 27 [cited 2025 Sep. 17];12(2). Available from: https://revistanefrologia.org/index.php/rcn/article/view/938